In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From UCB S.A.

FibroGen Misses In First Of Two Pivotal DMD Trials

The biotech’s pamrevlumab fails a Phase III study in non-ambulatory Duchenne muscular dystrophy, but the antibody still has a shot in ambulatory DMD, as well as IPF and pancreatic cancer.

Clinical Trials Business Strategies

Akero Shows FGF21/GLP-1 Combo’s Potential In NASH And Type 2 Diabetes

Phase IIb data show that Akero’s efruxifermin on top of GLP-1 therapy is relatively safe and offers liver fat reductions and fibrosis improvements in NASH patients with type 2 diabetes.

Clinical Trials Business Strategies

Dr Reddy’s CEO: We’re In ‘Great Dialogue’ With The Innovation Industry In China

Dr Reddy’s is collaborating with innovator firms in China, Israel and the US largely in areas of unmet need, propelling its “Horizon-2” strategy that encompasses segments like biologics and cell and gene therapy, digital services and immuno-oncology NCEs, among others.

Strategy Deals

China Roundup: Rare Disease Approvals, Local mRNA Shots, CEO Visits

AstraZeneca and CANbridge obtain new approvals for their rare disease drugs in China, where a new domestic mRNA vaccine is also being made available amid a new wave of COVID infections. Meanwhile, the CEOs of pharma and other companies pay visits, showing China remains high on their list of global priorities.

China Approvals
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Biotechnology
    • Antisense, Oligonucleotides
    • Large Molecule
    • Drug Discovery Technologies
      • Bioinformatics
      • Genomics-Proteomics
  • Other Names / Subsidiaries
    • Celltech Pharmaceuticals, Inc.
    • Element Genomics
    • Engage Therapeutics, Inc., Ra Pharmaceuticals, Inc.
    • Schwarz Pharma
    • UCB Biopharma
    • Upstate Pharma, LLC
UsernamePublicRestriction

Register